Eritrea vs India: Cause of death, by non-communicable diseases, ages 5-14, male
Eritrea
20.2%
in 2021
India
20.1%
in 2021
Eritrea rank
147th
India rank
148th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Eritrea
- India
How they compare
Eritrea currently reports 20.2% against 20.1% in India, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was India ahead.
Eritrea ranks 147th and India ranks 148th of 185 countries.
India has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.5% | 16.0% | 3.5% | India |
| 2010s | 17.4% | 19.5% | 2.1% | India |
| 2020s | 20.3% | 21.0% | 0.8% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Eritrea or India?
- Eritrea, at 20.2% against 20.1% in India as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Eritrea and India?
- 0.1%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and India?
- 6 years are reported by both, from 2000 to 2021.
- How do Eritrea and India rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Eritrea ranks 147th and India ranks 148th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.